← Leaderboards
Wayne A Ray
Vanderbilt University Medical Center
$20,620,953
Attributed
$20,620,953
Total exposure
9
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.5M · FY2005–23$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$16,001,725 · 7
AHRQ$4,619,228 · 2
By mechanism
R01$15,214,167 · 6
U18$4,619,228 · 2
R56$787,558 · 1
Top collaborators
No co-investigators on record.
Most similar at Vanderbilt University Medical Center
Same institution · by research overlap
- Carlos G Grijalva$7,760,476
- Nicholas Constantine Zachos$6,925,419
- Kelly E. Dooley$16,423,496
- Jane E Freedman$24,578,337
Others in their field
Top investigators on “Pharmaceutical Preparations”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$266,816,120
- Leonard Freedman · Leidos Biomedical Research, Inc.$240,520,687
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
- Lawrence Corey · Fred Hutchinson Cancer Center$196,976,947
Research focus
Pharmaceutical PreparationsSafetyTennesseeMedicaidDoseIncidenceClinical PracticeAntipsychotic AgentsAffectCardiovascular SystemCessation Of LifeAdultOralLinkDatabasesHigh RiskPreventAntidepressive AgentsCohortArrhythmiaCase StudyCohort StudiesErythromycinBase
Grant awards (46)
Outcomes of non-vitamin K anticoagulants in atrial fibrillation$815,499
R01 · FY2023 · HL · contact PI
Antipsychotics and the Risk of Unexpected Death in Children and Youth$634,090
R01 · FY2023 · HD · contact PI
Outcomes of non-vitamin K anticoagulants in atrial fibrillation$820,409
R01 · FY2022 · HL · contact PI
Antipsychotics and the Risk of Unexpected Death in Children and Youth$641,537
R01 · FY2022 · HD · contact PI
Outcomes of non-vitamin K anticoagulants in atrial fibrillation$833,641
R01 · FY2021 · HL · contact PI
Antipsychotics and the Risk of Unexpected Death in Children and Youth$632,356
R01 · FY2021 · HD · contact PI
Outcomes of non-vitamin K anticoagulants in atrial fibrillation$849,034
R01 · FY2020 · HL · contact PI
Antipsychotics and the Risk of Unexpected Death in Children and Youth$663,785
R01 · FY2020 · HD · contact PI
Antipsychotics and the Risk of Unexpected Death in Children and Youth$668,872
R01 · FY2019 · HD · contact PI
Prescription hypnotics and the risk of cardiovascular death$787,558
R56 · FY2018 · HL · contact PI
Prescribed Opioid Safety in Children$520,626
R01 · FY2017 · HD · contact PI
Preventing Gastroduodenal Bleeding in Oral Anticoagulant Users$569,939
R01 · FY2016 · HL · contact PI
Prescribed Opioid Safety in Children$466,424
R01 · FY2016 · HD · contact PI
Prescribed Opioid Safety in Children$85,043
R01 · FY2016 · HD · contact PI
Prescribed Opioid Safety in Children$573,563
R01 · FY2015 · HD · contact PI
Preventing Gastroduodenal Bleeding in Oral Anticoagulant Users$554,214
R01 · FY2015 · HL · contact PI
Medications and the Risk of Sudden Cardiac Death$334,079
R01 · FY2015 · HL · contact PI
Medications and the Risk of Sudden Cardiac Death$50,071
R01 · FY2015 · HL · contact PI
Prescribed Opioid Safety in Children$565,167
R01 · FY2014 · HD · contact PI
Preventing Gastroduodenal Bleeding in Oral Anticoagulant Users$455,639
R01 · FY2014 · HL · contact PI
Medications and the Risk of Sudden Cardiac Death$382,200
R01 · FY2014 · HL · contact PI
Prescribed Opioid Safety in Children$550,379
R01 · FY2013 · HD · contact PI
Preventing Gastroduodenal Bleeding in Oral Anticoagulant Users$467,604
R01 · FY2013 · HL · contact PI
Medications and the Risk of Sudden Cardiac Death$371,280
R01 · FY2013 · HL · contact PI
Medications and the Risk of Sudden Cardiac Death$390,000
R01 · FY2012 · HL · contact PI
Medications and the Risk of Sudden Cardiac Death$386,800
R01 · FY2011 · HL · contact PI
Vanderbilt Center for Education/Research on Therapeutics$966,744
U18 · FY2010 · HS · contact PI
Vanderbilt Center for Education/Research on Therapeutics$961,786
U18 · FY2009 · HS · contact PI
Medications and the Risk of Sudden Cardiac Death$363,864
R01 · FY2009 · HL · contact PI
Vanderbilt Center for Education/Research on Therapeutics$963,699
U18 · FY2008 · HS · contact PI
Medications and the Risk of Sudden Cardiac Death$363,864
R01 · FY2008 · HL · contact PI
Vanderbilt Center for Education/Research on Therapeutics$962,462
U18 · FY2007 · HS · contact PI
Medications and the Risk of Sudden Cardiac Death$363,765
R01 · FY2007 · HL · contact PI
Vanderbilt Center for Education/Research on Theraputics$764,537
U18 · FY2006 · HS · contact PI
Medications and the Risk of Sudden Cardiac Death$373,307
R01 · FY2006 · HL · contact PI
Medications and the Risk of Sudden Cardiac Death$380,000
R01 · FY2005 · HL
Vanderbilt Center for Education/Research on Theraputics$0
U18 · FY2005 · HS
Vanderbilt Center for Education/Research on Therapeutics$0
U18 · FY2005 · HS
Vanderbilt Center for Education/Research on Theraputics$0
U18 · FY2004 · HS
Vanderbilt Center for Education/Research on Theraputics$0
U18 · FY2003 · HS
Vanderbilt Center for Education/Research on Theraputics$0
U18 · FY2002 · HS
VANDERBILT CENTER FOR EDUCATION/RESEARCH ON THERAPEUTICS$0
U18 · FY2002 · HS
VANDERBILT CENTER FOR EDUCATION/RESEARCH ON THERAPEUTICS$0
U18 · FY2001 · HS
VANDERBILT CENTER FOR EDUCATION/RESEARCH ON THERAPEUTICS$0
U18 · FY2001 · HS
CLINICAL OUTCOMES OF A MENTAL HEALTH CARVE OUT$87,116
R01 · FY2000 · MH
VANDERBILT CENTER FOR EDUCATION/RESEARCH ON THERAPEUTICS$0
U18 · FY2000 · HS